MFOHome About Commentary Discussions Funds The Best Resources Support Us!

Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Sign In Register

Categories

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

MFS Mid Cap Growth Fund Outperforms Thanks To Leaders Like Abiomed: (OTCIX)

TedTed
in The Bullpen
FYI: MFS Mid Cap Growth Fund (OTCIX) is flexing its muscles. After topping 69% of its midcap growth rivals tracked by Morningstar.com last year with a 26.29% return, the $3.1 billion portfolio is outpacing 86% of its peers with a 15.33% gain this year going into June 21.
Regards,
Ted
https://www.investors.com/etfs-and-funds/mutual-funds/mfs-mid-cap-growth-fund-outperforms-leaders-abiomed/

M* Snapshot OTCIX:
https://www.morningstar.com/funds/xnas/otcix/quote.html

Lipper Snapshot OTCIX:
https://www.marketwatch.com/investing/fund/otcix

OTCIX Is Unranked In The (MCG) Fund Category By U.S. News & World Report:
https://money.usnews.com/funds/mutual-funds/mid-cap-growth/mfs-mid-cap-growth-fund/otcix
Sign In or Register to comment.